12 employees
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics.
2020
$125K
from 1 investors over 1 rounds
Adaptyv Bio raised $125K on August 4, 2021
Investors: Y Combinator